Return to Article Details
LOSS OF HETEROZYGOSITY AT THE BRCA1 LOCUS AS A MARKER OF SEN- SITIVITY FOR ADJUVANT CHEMOTHERAPY IN HEREDITARY OVARIAN CANCER
Download
Download PDF